“Real-World Effectiveness of Upadacitinib in Moderate‑to‑Severe Atopic Dermatitis (AD): Results From Longitudinal Analyses of the CorEvitas AD Registry”. SKIN The Journal of Cutaneous Medicine 8, no. 6 (November 18, 2024): s450. Accessed May 18, 2025. https://skin.dermsquared.com/skin/article/view/3052.